rs140764964

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_032968.5(PCDH11X):​c.718A>T​(p.Thr240Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000252 in 1,208,038 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 99 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00030 ( 0 hom., 5 hem., cov: 20)
Exomes 𝑓: 0.00025 ( 0 hom. 94 hem. )

Consequence

PCDH11X
NM_032968.5 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 3.02

Publications

0 publications found
Variant links:
Genes affected
PCDH11X (HGNC:8656): (protocadherin 11 X-linked) This gene belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. The encoded protein consists of an extracellular domain containing 7 cadherin repeats, a transmembrane domain and a cytoplasmic tail that differs from those of the classical cadherins. The gene is located in a major X/Y block of homology and its Y homolog, despite divergence leading to coding region changes, is the most closely related cadherin family member. The protein is thought to play a fundamental role in cell-cell recognition essential for the segmental development and function of the central nervous system. Disruption of this gene may be associated with developmental dyslexia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.13381535).
BP6
Variant X-91876958-A-T is Benign according to our data. Variant chrX-91876958-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1087134.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.
BS2
High Hemizygotes in GnomAd4 at 5 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCDH11XNM_032968.5 linkc.718A>T p.Thr240Ser missense_variant Exon 6 of 11 ENST00000682573.1 NP_116750.1 Q9BZA7-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCDH11XENST00000682573.1 linkc.718A>T p.Thr240Ser missense_variant Exon 6 of 11 NM_032968.5 ENSP00000507225.1 Q9BZA7-1

Frequencies

GnomAD3 genomes
AF:
0.000300
AC:
33
AN:
109904
Hom.:
0
Cov.:
20
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000494
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000352
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000473
Gnomad OTH
AF:
0.000674
GnomAD2 exomes
AF:
0.000229
AC:
42
AN:
183292
AF XY:
0.000162
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000109
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000500
Gnomad NFE exome
AF:
0.000367
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.000247
AC:
271
AN:
1098091
Hom.:
0
Cov.:
31
AF XY:
0.000259
AC XY:
94
AN XY:
363565
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26397
American (AMR)
AF:
0.000114
AC:
4
AN:
35200
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19384
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54143
European-Finnish (FIN)
AF:
0.000543
AC:
22
AN:
40534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4132
European-Non Finnish (NFE)
AF:
0.000280
AC:
236
AN:
842010
Other (OTH)
AF:
0.000152
AC:
7
AN:
46086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000300
AC:
33
AN:
109947
Hom.:
0
Cov.:
20
AF XY:
0.000156
AC XY:
5
AN XY:
32137
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30253
American (AMR)
AF:
0.000493
AC:
5
AN:
10133
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2642
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3504
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2528
European-Finnish (FIN)
AF:
0.000352
AC:
2
AN:
5676
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
214
European-Non Finnish (NFE)
AF:
0.000473
AC:
25
AN:
52808
Other (OTH)
AF:
0.000665
AC:
1
AN:
1503
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000218
Hom.:
1
Bravo
AF:
0.000287
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000743
AC:
5
ExAC
AF:
0.000206
AC:
25
EpiCase
AF:
0.000273
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 20, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.718A>T (p.T240S) alteration is located in exon 2 (coding exon 2) of the PCDH11X gene. This alteration results from a A to T substitution at nucleotide position 718, causing the threonine (T) at amino acid position 240 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Jan 02, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.084
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
6.4
DANN
Benign
0.77
DEOGEN2
Benign
0.032
.;T;.;.;.;.
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.52
T;T;T;T;T;T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.13
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.4
L;L;L;L;L;L
PhyloP100
3.0
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.3
N;N;N;N;N;N
REVEL
Benign
0.088
Sift
Benign
0.69
T;T;T;T;T;T
Sift4G
Benign
0.70
T;T;T;T;T;T
Polyphen
0.0090
B;B;B;B;B;B
Vest4
0.098
MutPred
0.52
Gain of disorder (P = 0.0553);Gain of disorder (P = 0.0553);Gain of disorder (P = 0.0553);Gain of disorder (P = 0.0553);Gain of disorder (P = 0.0553);Gain of disorder (P = 0.0553);
MVP
0.72
MPC
1.0
ClinPred
0.040
T
GERP RS
-0.33
Varity_R
0.074
gMVP
0.15
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140764964; hg19: chrX-91131957; API